David T. Hung

Biography

David T. Hung has served as Chief Executive Officer of Axovant Sciences, Inc. and a member of the board since April 2017. Previously, he was a co-founder of Medivation, Inc., a biopharmaceutical company, and served as its President and Chief Executive Officer and a member of its board of directors until its acquisition by Pfizer Inc. Before that, Dr. Hung was employed by ProDuct Health, Inc., a privately held medical device company, as Chief Scientific Officer and then as President and Chief Executive Officer. He has also served as a consultant to Cytyc Corporation to assist with transitional matters related to its acquisition of ProDuct Health, Inc. and has served as a member of the board of directors of Opexa Therapeutics, Inc., a biopharmaceutical company. He received an MD from the University of California, San Francisco, School of Medicine, and an AB in biology from Harvard College.

Research Interest

neurology, CNS drugs, Alzheimer’s disease and dementia, Balance Impairments, REM Sleep Behavior Disorder, biopharmaceuticals, biology.